Deep and Durable Responses Following Venetoclax (ABT-199 / GDC-0199) Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from a Phase 1b StudyShuo Ma, Andrew W. Roberts, Jacqueline C. Barrientos et al.|Blood|2015Cited by 50
Pooled Multi-Trial Analysis of Venetoclax Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic LeukemiaAndrew W. Roberts, Michael Hallek, John F. Seymour et al.|Blood|2016Cited by 14